Duquesne Family Office’s TG Therapeutics TGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-280,000
Closed -$4.26M 85
2024
Q1
$4.26M Buy
+280,000
New +$4.26M 0.1% 66